Recent Advances in Cryptococcus and Cryptococcosis
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (31 January 2023) | Viewed by 11288
Special Issue Editors
Interests: Cryptococcus neoformans; Cryptococcus gattii; cryptococcosis
Interests: molecular medical mycology; fungal population genetics; fungal phylogeny and taxonomy; fungal virulence; molecular epidemiology of human pathogenic fungi; fungal disease outbreak investigation; fungal strain typing; early fungal disease diagnostic
Special Issue Information
Dear Colleagues,
Cryptococcosis is a potentially fatal fungal disease mainly caused by Cryptococcus neoformans, an environmental encapsulated yeast that predominantly affects immunocompromised patients, especially people living with HIV. As a primary mycosis, however, cryptococcosis is primarily caused by its sibling species, Cryptococcus gattii, as this yeast affects people with no apparent risk factors. Cryptococcal meningitis, which is the main presentation of cryptococcosis, remains a significant clinical and economic burden in adults from many countries where there is a high HIV seroprevalence. Despite significant improvements in antifungal and antiretroviral therapy, cryptococcosis is still associated with high morbidity and mortality. The goal of this Special Issue is to provide an update on the most current studies on the pathogenesis, virulence factors, antifungal susceptibility, and population genetics of C. neoformans and C. gattii, as well as on the epidemiology, clinical aspects, diagnosis, and treatment of cryptococcosis, both through reviews and original research articles.
Dr. Carolina Firacative
Prof. Dr. Wieland Meyer
Dr. Luciana Trilles
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
